IL17A and neoplasm: Taken together, intra-tumoral T-cell analysis revealed higher infiltration and increased proportions of effector T cells in SC models than in BOT models, along with an accumulation of IL17A+ γδ T cells and Treg cells in SC models, suggesting a more robust but complex anti-tumor immune environment involving both anti-tumor and pro-tumor pathways.